Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2025-12-25 @ 2:52 AM
NCT ID:
NCT00434733
Eligibility Criteria:
Inclusion Criteria:
* Healthy Subjects 18 years of age who signed the informed consent
Exclusion Criteria:
* Receipt of another investigational agent within 4 weeks
* Receipt of influenza vaccination for current season 2006/2007.
* any acute disease or infection, history of neurological symptoms or signs, known or suspected impairment of immune function, any serious disease, bleeding diathesis
* fever (defined as axillary temperature ³38.0°C) within 3 days (prior to Visit 1)
* Pregnant or breastfeeding or females of childbearing potential who refuse to use an acceptable method of birth control
* Surgery planned during the study period
* Hypersensitivity to eggs, chicken protein, chicken feathers, influenza viral protein, neomycin or polymyxin or any other component of the study vaccine
* Receipt of another vaccine within 3 weeks prior to Visit 1 or planned vaccination within 3 weeks following the last study vaccination
* History of (or current) drug or alcohol abuse
* Any condition, which, in the opinion of the Investigator, might interfere with the evaluation of the study objectives.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00434733
Study Brief:
Protocol Section:
NCT00434733